Search results for "Forming"

showing 10 items of 1719 documents

Regulation of the type II oncostatin M receptor expression in lung-derived epithelial cells

1998

AbstractOncostatin M (OSM) is a potent modulator of human lung-derived epithelial cell function. This cytokine binds two distinct receptor complexes: type I OSM receptor which is also a functional receptor for leukemia inhibitory factor (LIF), and type II OSM-specific receptor. The role of these two distinct receptors in mediating the response of individual cell types to OSM has not been delineated. In contrast to LIF, OSM induces synthesis of α1-antichymotrypsin and α1-antiproteinase inhibitor in lung-derived epithelial cells. The differential responsiveness to LIF and OSM suggested that the response of lung epithelial cells to OSM may be mediated by the OSM-specific receptor. Therefore, w…

Cell typemedicine.medical_treatmentTransforming growth factor β1Respiratory SystemBronchial epitheliumBiophysicsBronchiOncostatin MInterleukin 1 receptor type IILeukemia Inhibitory FactorBiochemistryDexamethasoneAntigens CDStructural BiologyCytokine Receptor gp130GeneticsmedicineHumansReceptors CytokineReceptorLungMolecular BiologyLymphokinesMembrane GlycoproteinsbiologyInterleukin-6ChemistryfungiOncostatin MOncostatin M receptorEpithelial CellsReceptors Oncostatin MCell BiologyGrowth InhibitorsCell biologyInterleukin 31CytokineGene Expression Regulationbiology.proteinCancer researchCytokinesInflammation MediatorsPeptidesLeukemia inhibitory factorFEBS Letters
researchProduct

Th9 cells, new players in adaptive immunity.

2014

Upon antigen-specific stimulation, naive CD4⁺ T cells have the potential to differentiate into various T helper (Th) cell subsets. Earlier models of Th cell differentiation focused on IFN-γ-producing Th1 cells and IL-4-secreting Th2 cells. The discovery of additional CD4⁺ Th cell subsets has extended our understanding of Th cell differentiation beyond this dichotomy. Among these is the recently described Th9 cell subset, which preferentially produces interleukin (IL)-9. Here, we review the latest developments in Th9 cell development and differentiation, focusing on contributing environmental signals, and discuss potential physiological and pathophysiological functions of these cells. We des…

Cellular differentiationImmunologyReceptors Antigen T-CellAdaptive ImmunityMiceT-Lymphocyte SubsetsTransforming Growth Factor betaNeoplasmsmedicineHypersensitivityImmunology and AllergyAnimalsHumansInterleukin 9Interleukin 4biologyCell growthLymphocyte differentiationInterleukin-9Models ImmunologicalReceptors Interleukin-2Transforming growth factor betaT helper cellT-Lymphocytes Helper-InducerAcquired immune systemReceptors Interleukin-4medicine.anatomical_structureImmunologyInterferon Regulatory Factorsbiology.proteinSignal TransductionTrends in immunology
researchProduct

Caveolin and GLT-1 gene expression is reciprocally regulated in primary astrocytes: Association of GLT-1 with non-caveolar lipid rafts

2004

Caveolae represent membrane microdomains acting as integrators of cellular signaling and functional processes. Caveolins are involved in the biogenesis of caveolae and regulate the activity of caveolae-associated proteins. Although caveolin proteins are found in the CNS, the regulation of caveolins in neural cells is poorly described. In the present study, we investigated different modes and mechanisms of caveolin gene regulation in primary rat astrocytes. We demonstrated that activation of cAMP-dependent signaling pathways led to a marked reduction in protein levels of caveolin-1/-2 in cortical astrocytes. Application of transforming growth factor-alpha (TGF-alpha) also resulted in a decre…

Central Nervous SystemCaveolin 2Caveolin 1Down-RegulationGlutamic AcidBiologyCaveolinsHistone DeacetylasesChromatin remodelingRats Sprague-DawleyPhosphatidylinositol 3-KinasesCellular and Molecular NeuroscienceAstrocyte differentiationMembrane MicrodomainsCaveolaeCaveolinCyclic AMPAnimalsRNA MessengerLipid raftCerebral CortexRegulation of gene expressionTransforming Growth Factor alphaRatsCell biologyCaveolin 2Animals NewbornExcitatory Amino Acid Transporter 2Gene Expression RegulationNeurologyAstrocytesCaveolin 1Signal TransductionGlia
researchProduct

Pharmacological Suppression of CNS Scarring by Deferoxamine Reduces Lesion Volume and Increases Regeneration in an In Vitro Model for Astroglial-Fibr…

2015

Lesion-induced scarring is a major impediment for regeneration of injured axons in the central nervous system (CNS). The collagen-rich glial-fibrous scar contains numerous axon growth inhibitory factors forming a regeneration-barrier for axons. We demonstrated previously that the combination of the iron chelator 2,2'-bipyridine-5,5'-decarboxylic acid (BPY-DCA) and 8-Br-cyclic AMP (cAMP) inhibits scar formation and collagen deposition, leading to enhanced axon regeneration and partial functional recovery after spinal cord injury. While BPY-DCA is not a clinical drug, the clinically approved iron chelator deferoxamine mesylate (DFO) may be a suitable alternative for anti-scarring treatment (A…

Central Nervous SystemCollagen Type IVmedicine.medical_specialtyNeuriteCentral nervous systemlcsh:MedicineBiologyPharmacologyDeferoxamineIn Vitro TechniquesIron Chelating AgentsCicatrixIn vivoTransforming Growth Factor betamedicineCyclic AMPNeuritesAnimalsHumansRNA MessengerAxonRats Wistarlcsh:ScienceSpinal cord injurySpinal Cord InjuriesMultidisciplinaryDeferoxamine mesylatelcsh:RFibroblastsSpinal cordmedicine.diseaseAxonsSurgeryNerve RegenerationRatsDeferoxamineDisease Models Animalmedicine.anatomical_structureAstrocyteslcsh:QFemalemedicine.drugResearch ArticlePloS one
researchProduct

Anticoagulation in splanchnic and cerebral vein thrombosis: Still groping in the dark.

2020

Cerebral veinsmedicine.medical_specialtybusiness.industrymedicine.drug_classSplanchnic Circulation10031 Clinic for Angiology2720 HematologyAnticoagulantanticoagulantvenous thromboembolism610 Medicine & healthHematologyCerebral vein thrombosisbleedingcerebral veinsplanchnic circulationsInternal medicineCardiologyCommentaryMedicineDiseases of the blood and blood-forming organsRC633-647.5businessSplanchnicVenous thromboembolismResearch and practice in thrombosis and haemostasis
researchProduct

Screening of ceria-based catalysts for internal methane reforming in low temperature SOFC

2010

Gaudillere, Cyril Vernoux, Philippe Mirodatos, Claude Caboche, Gilles Farrusseng, David 6th World Congress on Oxidation Catalysis (6WCOC) JUL 05-10, 2009 Lille, FRANCE; International audience; Ceria-based catalysts have been assessed for internal methane reforming at low temperature (400-600 C) in Solid Oxide Fuel Cell (SOFC) A combinatorial library of 15 metal (Cu Pt Ni) supported ceria was prepared using wet impregnation method The ceria-based oxides are undoped or doped with metal transition (Zr) or by rare earth (Gd or Pr) The effect of the metal the dopant and the surface area on the catalytic performances was investigated in high-throughput manner using a 16-parallel reactor The catal…

Cerium oxideMethane reformerDopantChemistryInorganic chemistry02 engineering and technologyGeneral Chemistry[CHIM.CATA]Chemical Sciences/Catalysis010402 general chemistry021001 nanoscience & nanotechnologyHeterogeneous catalysis01 natural sciences[SDE.ES]Environmental Sciences/Environmental and SocietyCatalysisMethane0104 chemical sciencesCatalysischemistry.chemical_compoundCatalytic reforming13. Climate actionSolid oxide fuel cell0210 nano-technology
researchProduct

Evaluation of bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in cervical cancer: Data from phase 1 and phase 2 studies.

2021

5509 Background: The accelerated FDA approval of pembrolizumab validated the efficacy of anti–PD-(L)1 therapy for pts with recurrent/metastatic cervical cancer; however, the objective response rate (ORR) with pembrolizumab was 14.3% in pts with PD-L1 expressing tumors. HPV infection is implicated in > 95% of cervical cancers and is linked to upregulation of TGF-β signaling. Bintrafusp alfa is a first-in-class bifunctional fusion protein composed of the extracellular domain of the TGF-βRII receptor (a TGF-β “trap”) fused to a human IgG1 mAb blocking PD-L1. We report pooled safety and efficacy in pts with immune checkpoint inhibitor–naive, recurrent/metastatic cervical cancer treated with…

Cervical cancerCancer Researchbiologybusiness.industryFda approvalPembrolizumabmedicine.diseaseFusion proteinOncologyPD-L1medicineCancer researchbiology.proteinbusinessObjective responseMetastatic cervical cancerTransforming growth factorJournal of Clinical Oncology
researchProduct

Caries arresting effect of silver diamine fluoride on dentine carious lesion with S. mutans and L. acidophilus dual-species cariogenic biofilm

2013

OBJECTIVES: This in vitro study investigated the effects of silver diamine fluoride (SDF) on dentine carious lesion with cariogenic biofilm. STUDY DESIGN: Thirty human dentine blocks were inoculated with Streptococcus mutans and Lactobacillus acidophilus dual-species biofilm to create carious lesion. They were equally divided into test and control group to receive topical application of SDF and water. After incubation anaerobically using micro-well plate at 37oC for 7 days, the biofilms were evaluated for kinetics, morphology and viability by colony forming units (CFU), scanning electron microscopy (SEM), and confocal microscopy (CLSM), respectively. The carious lesion underwent crystal cha…

Chemical structureOdontologíaDental CariesMicrobiologyStreptococcus mutansCrystallinityLactobacillus acidophilusstomatognathic systemHumansSilver diamine fluorideFluorides TopicalGeneral DentistryColony-forming unitOral Medicine and PathologybiologyChemistryBiofilmSilver Compoundsbiology.organism_classification:CIENCIAS MÉDICAS [UNESCO]Streptococcus mutansCiencias de la saludDemineralizationLactobacillus acidophilusQuaternary Ammonium CompoundsOtorhinolaryngologyBiofilmsUNESCO::CIENCIAS MÉDICASSurgeryResearch-ArticleNuclear chemistryMedicina Oral, Patología Oral y Cirugía Bucal
researchProduct

Quantification of growth factors by using a new system for obtaining platelet-rich plasma

2010

Objective: To verify the performance of a new method for obtaining platelet-rich plasma, while avoiding contami- nation of the sample during its processing. Study Design: Twenty healthy patients were selected, from whom 21 ml of blood was etracted. �e then pro- Design: Twenty healthy patients were selected, from whom 21 ml of blood was etracted. �e then pro- esign: Twenty healthy patients were selected, from whom 21 ml of blood was etracted. �e then pro- ceeded to study the platelets and growth factors in basal blood after centrifuging the sample by using a new closed system for obtaining platelet-rich plasma (PRP). Results: After centrifuging the blood sample, double the amount of platelet…

ChemistryPlatelet-Rich PlasmaGrowth factormedicine.medical_treatmentInsulinCentrifugationHematology:CIENCIAS MÉDICAS [UNESCO]AndrologyYoung AdultOtorhinolaryngologyBasal (medicine)Platelet-rich plasmaImmunologyUNESCO::CIENCIAS MÉDICASmedicineHumansIntercellular Signaling Peptides and ProteinsSurgeryPlateletPlatelet concentrateSistema circulatorioGeneral DentistryTransforming growth factor
researchProduct

Spleen Tyrosine Kinase (SYK) in the Progression of Peritoneal Fibrosis Through Activation of the TGF-β1/Smad3 Signaling Pathway.

2019

BACKGROUND Long-term exposure to hypertonic and high glucose in peritoneal dialysis fluid can result in peritoneal fibrosis. Spleen tyrosine kinase (SYK) has a role in inflammation and fibrosis. This study aimed to investigate the role of SYK in an in vivo rat model of peritoneal fibrosis and in rat peritoneal mesothelial cells (PMCs) in vitro and to investigate the underlying mechanisms. MATERIAL AND METHODS Sprague-Dawley rats (N=24) were randomized into the sham control group (N=6); the peritoneal fibrosis group (N=6) treated with intraperitoneal chlorhexidine digluconate; the SYK inhibitor group (N=6), treated with chlorhexidine digluconate and fostamatinib; and the TGF-s inhibitor grou…

ChinaSykInflammation030204 cardiovascular system & hematologyPharmacologyFostamatinibRats Sprague-DawleyTransforming Growth Factor beta103 medical and health sciences0302 clinical medicineWestern blotIn vivoFibrosismedicineAnimalsSyk KinaseSmad3 ProteinPeritoneal Fibrosismedicine.diagnostic_testChemistryAnimal StudyChlorhexidinePeritoneal FibrosisGeneral Medicinemedicine.diseaseRatsDisease Models AnimalNephrology030220 oncology & carcinogenesisDisease Progressionmedicine.symptomPeritoneumPeritoneal DialysisTransforming growth factormedicine.drugSignal TransductionMedical science monitor : international medical journal of experimental and clinical research
researchProduct